Hemin enhances the cardioprotective effects of mesenchymal stem cell-derived exosomes against infarction via amelioration of cardiomyocyte senescence
Hemin
Senescence
DOI:
10.1186/s12951-021-01077-y
Publication Date:
2021-10-21T12:02:36Z
AUTHORS (17)
ABSTRACT
Application of mesenchymal stem cell-derived exosomes (MSC-EXO) has emerged as a novel therapeutic strategy for myocardial infarction (MI). Our previous study showed that pretreatment with hemin, potent heme oxygenase-1 (HO-1) inducer, enhanced the cardioprotective effects MSCs in mouse model MI. This aimed to investigate EXO derived from hemin-pretreated (Hemin-MSC-EXO) MI and explore potential mechanisms.MSC-EXO Hemin-MSC-EXO were collected characterized. MSC-EXO intramuscularly injected into peri-infarct region Heart function mice was assessed by echocardiography. The mitochondrial morphology neonatal cardiomyocytes (NMCMs) under serum deprivation hypoxic (SD/H) conditions examined Mitotracker staining. cellular senescence NMCMs determined senescence-associated-β-galactosidase assay. A loss-of-function approach adopted determine role Hemin-MSC-exosomal-miR-183-5p regulation cardiomyocyte RESULTS: successfully isolated supernatant Hemin-pretreated MSCs. Compared MSC-EXO, injection significantly improved cardiac reduced fibrosis. Both ameliorated fission vitro vivo, latter exhibited better protective effects. MicroRNA sequencing revealed higher level miR-183-5p than MSC-EXO. MiR-183-5p knockdown partially abrogated attenuating induced SD/H. High mobility group box-1 (HMGB1) abundance lower Hemin-MSC-EXO-treated MSC-EXO-treated hearts, HMGB1 identified one target genes miR-183-5p. Mechanistically, inhibited SD/H-induced delivering recipient via HMGB1/ERK pathway. Furthermore, Hemin-MSC-EXO-mediated MI.Our results reveal are superior treating Exosomal mediates, at least partially, inhibiting highlights have high translational value repairing dysfunction following infarction.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (67)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....